Home > Income Statement > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Revenue

    Back to Income Statement
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹48,497 Cr₹43,886 Cr₹38,654 Cr₹33,498 Cr₹32,838 Cr

What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Revenue ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹48,497 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹48,497 Cr
Mar2023₹43,886 Cr
Mar2022₹38,654 Cr
Mar2021₹33,498 Cr
Mar2020₹32,838 Cr

How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Revenue % Change
Mar2024 ₹48,497 Cr
10.51
Mar2023 ₹43,886 Cr
13.53
Mar2022 ₹38,654 Cr
15.39
Mar2021 ₹33,498 Cr
2.01
Mar2020 ₹32,838 Cr -

Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹431,346.2 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
MANKIND PHARMA ₹102,231.0 Cr -2.1% -0.6% 33.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

1.7%

-4.7%

48.8%

SENSEX

1.8%

-2.5%

19.9%


You may also like the below Video Courses